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Endovascular aneurysm repair (EVAR) has become the standard 
of care for the treatment of infrarenal abdominal aortic aneu-
rysms (AAA). Despite numerous advances in EVAR devices, 
the need for secondary interventions to treat complications such 
as endoleaks and migration remains an issue.1,2 One of the latest 
innovations is endovascular aneurysm sealing (EVAS), a tech-
nique based on polymer filling of endobags surrounding dual 
stent frames that aimed to prevent endoleaks of any type.3 Early 
results were promising, but the applicability was reduced signifi-
cantly by a refinement of the instructions for use (IFU), driven 
by the incidence of late failures.3,4
Like EVAR, a prosthetic graft infection may also occur 
after EVAS. Prosthetic graft infection, with an incidence 
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Abstract
Purpose: To investigate the physiological uptake of hybrid fluorine-18-fluorodeoxyglucose (FDG)–positron emission 
tomography/computed tomography (PET/CT) before and after an uncomplicated endovascular aneurysm sealing (EVAS) 
procedure as a possible tool to diagnose EVAS graft infection and differentiate from postimplantation syndrome. Materials 
and Methods: Eight consecutive male patients (median age 78 years) scheduled for elective EVAS were included in the 
prospective study (ClinicalTrials.gov identifier NCT02349100). FDG-PET/CT scans were performed in all patients before the 
procedure and 6 weeks after EVAS. The abdominal aorta was analyzed in 4 regions: suprarenal, infrarenal neck, aneurysm 
sac, and iliac. The following parameters were obtained for each region: standard uptake value (SUV), tissue to background 
ratio (TBR), and visual examination of FDG uptake to ascertain its distribution. Demographic data were obtained from 
medical files and scored based on reporting standards. Results: Visual examination showed no difference between pre- 
and postprocedure FDG uptake, which was homogenous. In the suprarenal region no significant pre- and postprocedure 
differences were observed for the SUV and TBR parameters. The infrarenal neck region showed a significant decrease in 
the SUV and no significant decrease in the TBR. The aneurysm sac and iliac regions both showed a significant decrease in 
SUV and TBR between the pre- and postprocedure scans. Conclusion: Physiological FDG uptake after EVAS was stable 
or decreased with regard to the preprocedure measurements. Future research is needed to assess the applicability and 
cutoff values of FDG-PET/CT scanning to detect endograft infection after EVAS.
Keywords
aortic aneurysm, endovascular aneurysm sealing, fluorine-18-fluorodeoxyglucose, graft infection, positron emission 
tomography / computed tomography
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ranging from 0.16% to 0.77%, is a life-threatening compli-
cation with a mortality rate of 18% to 50%.5–7 Diagnosing 
vascular prosthetic graft infection is a challenge as clinical 
signs vary greatly and are often nonspecific.8 In the early 
phase after implantation, the postimplantation syndrome 
(PIS) might interfere with the diagnosis of a true infection.9
Hybrid fluorine-18-fluorodeoxyglucose (FDG) positron 
emission tomography (PET) combined with computed 
tomography (FDG-PET/CT) is frequently used as the pre-
ferred diagnostic tool for graft infection.3,10 Visual exami-
nation, the standard uptake value (SUV), and the tissue to 
background ratio (TBR) are parameters that reflect the 
intensity of FDG uptake. A linear, diffuse, and homoge-
neous uptake is not indicative of an infection, whereas focal 
or heterogeneous uptake with a projection matching the 
vessel on CT is highly suggestive.11 In addition to infection, 
a (moderately) increased FDG uptake is also associated 
with scar tissue, native vessels, and postsurgical inflamma-
tory changes.12 A chronic aseptic inflammation due to the 
synthetic graft material mediated primarily by fibroblasts, 
foreign-body giant cells, and macrophages may also cause a 
potential base for some FDG uptake.13,14 False-positive 
FDG-PET/CT imaging may result in a diagnostic error and 
antibiotic overuse, particularly in the first 6 to 8 weeks after 
surgery.15
Little is known about the physiological FDG uptake 
after EVAR. A recent publication by Marie et al16 showed 
no increased FDG uptake 1 month after EVAR compared 
with the preprocedure FDG uptake. However, after 6-month 
follow-up a significant increase in FDG uptake was 
observed, which was related to patients with minimal AAA 
shrinkage.
So far, no study has provided information on the physi-
ological FDG uptake after EVAS. This is important to 
assess the applicability of FDG-PET/CT scanning for the 
detection of an (early) endograft infection. Therefore, a 
study was undertaken to examine the physiological effect of 
EVAS on the FDG uptake in the vascular wall in patients 
who underwent an uncomplicated EVAS procedure.
Materials and Methods
Study Design
This prospective, within-subject, exploratory study evalu-
ated patients scheduled for elective AAA treatment using 
the Nellix endoprosthesis (Endologix, Irvine, CA, USA) 
between January 2015 and January 2017. Patients were 
ineligible for the study if they had diabetes, known inflam-
matory disease, or malignancy. Medical files of the included 
patients were screened for demographic data and scored 
according to the reporting standards.17
This study was conducted in accordance with the prin-
ciples of the Declaration of Helsinki and Good Clinical 
Practice guidelines. The study was approved by the medical 
ethics committee of the region Arnhem-Nijmegen 
(NL50251.091.14) and the local institutional review board. 
All participants in the study gave informed consent. The 
trial was registered on the National Institutes of Health 
website (ClinicalTrials.gov; identifier NCT02349100).
EVAS Technique. The procedures were performed accord-
ing to the manufacturer’s IFU and under antibiotic pro-
phylaxis, as previously described.18 Briefly, after gaining 
access to the femoral arteries, angiography with a cali-
brated catheter was performed to establish the specific 
device length needed. After positioning the devices so that 
the endobags were below the most caudal renal artery, the 
outer sheaths were retracted. The endobags are evacuated, 
and the stent balloons were simultaneously inflated to 
deploy the stents. A prefill of the endobags was performed 
with nonheparinized saline under pressure monitoring to 
assess the volume of polymer required to exclude the 
aneurysm. After emptying the endobags, the polymer was 
injected at a target pressure of 180 mm Hg. During poly-
mer curing the balloons were reinflated. After polymer 
filling, final angiography was performed to confirm the 
complete seal of the aneurysm sac and absence of 
endoleaks.
Scanning Protocol. FDG-PET/CT scans (Philips Gemini 
TF64; Philips Medical Systems, Best, the Netherlands) 
were performed in all patients before and 6 weeks after 
treatment. FDG (Cyclotron BV, Amsterdam, the Nether-
lands) was used as a tracer for detection of inflammatory 
activity. Patients had to fast for 6 hours prior to scanning 
and drink 1 L of water 2 hours prior to scanning. One hour 
prior to scanning the FDG was administered intravenously, 
and the patients rested for 30 minutes. The administered 
amount of FDG (Mbq) was based on patient body weight 
(bw) [(3.125/kg bw) * 1.17 MBq]. Data concerning body 
mass index (BMI), glucose levels, and FDG doses and scan-
ning time were recorded for each scan.
IDS7 (version 19.1; Sectra, Linköping, Sweden) was 
used to analyze the FDG-PET/CT scans. Regions of inter-
est (ROI) were drawn using a free hand tool. The SUVmax, 
defined as the SUV of the voxel with the highest SUV 
within a selected ROI, was used for semiquantitative anal-
ysis of the FDG-PET/CT data. The program automatically 
corrected for BMI and the time of injection. Correction for 
glucose was performed manually using a correction factor 
[glucose level (mmol/L) / 5 (mmol/L) * SUV]. 
Furthermore, TBR, which represents the SUV corrected 
for background noise, was calculated by dividing the 
SUVmax by the SUVmax of the ascending aorta blood 
pool lumen. The slice where the ascending aorta was 
observed as a round structure was used for calculations. 
The abdominal aorta was divided in 4 subregions as 
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depicted in Figure 1. Five consecutive slices were selected 
in the cranial direction for the suprarenal region and 
another 5 consecutive slices below the lowest renal artery 
for the infrarenal neck region. The aneurysm sac region 
was defined over 5 equally spaced slices between the last 
slice of the infrarenal neck region and the apex of the aor-
tic bifurcation. The iliac region consisted of 5 consecutive 
slices selected caudal of the apex of the aortic bifurcation. 
In every slice, the SUVmax was determined in a manually 
selected ROI (Figure 2) around the edges of the activity of 
the vascular wall. Thrombus and/or calcification were 
included in the ROI.
Besides determination of the SUV and TBR, visual 
assessment was performed by a nuclear medicine physician 
(RS). The FDG-PET/CT scans were assessed on heteroge-
neity and intensity of FDG uptake, which was graded on a 
4-point scale.11 Grade 1 is an FDG uptake similar to that in 
the background. Grade 2 implies low FDG uptake and is 
comparable with the FDG uptake by inactive muscles and 
fat. Grade 3 reflects moderate FDG uptake, clearly visible 
and higher than the uptake by inactive muscles and fat but 
distinctly less than the physiological urinary uptake by the 
bladder. Grade 4 means a strong FDG uptake, comparable 
to the physiological uptake by the bladder. The assessment 
of heterogeneity was classified as homogeneous, slightly 
heterogeneous, or heterogeneous.
Statistical Analysis
Data are reported as the median and interquartile range 
(IQR; Q1, Q3). Significant differences between the pre and 
post SUV and TBR were analyzed using the Wilcoxon test 
because of the small sample size and expected nonnormal 
distribution of the data. Wilcoxon tests were also employed 
to assess whether the nonnormally distributed visual exami-
nations were significantly different between the pre- to 
postprocedure examinations. Descriptive statistics were 
given for all values and measurements. Differences were 
considered significant at the p<0.05 level. Data were ana-
lyzed using SPSS software (version 25; IBM Corporation, 
Armonk, NY, USA).
Figure 1. Overview of measurement regions. The arrows indicate the direction of measurement.
Figure 2. FDG-PET/CT fused-image axial slice of the abdomen 
including the region of interest (white lines) on the first slice 
of the infrarenal neck region showing infrarenal anatomy 
(A) before and (B) after endovascular aneurysm sealing; CT, 
computed tomography; FDG, fluorine-18-fluorodeoxyglucose; 
PET, positron emission tomography.
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Results
Of 11 patients recruited for the study, 8 male patients 
(median age 78 years) were analyzed after exclusion of 3 
unevaluable cases. Two patients were excluded because a 
malignancy was detected on the preprocedure FDG-PET/
CT; the third was converted to open repair during surgery 
due to occlusion of the left renal artery by a bulging left 
endobag after secondary fill. The baseline patient character-
istics are given in Table 1, parameters of the FDG-PET/CT 
scans are summarized in Table 2, and operative details are 
given in Table 3.
Visual examination of the FDG-PET/CT scans showed 
no significant differences between the pre- and postproce-
dure studies (Table 4). All but 1 patient showed homoge-
nous uptake, comparable to the background signal. Slightly 
heterogeneous but low uptake was observed in 1 patient due 
to increased uptake in the prostate and left abdomen.
SUV and TBR outcomes per region are displayed in 
Table 5. In the suprarenal region there were no significant 
differences between pre- and postprocedure SUVmax and 
TBR. For the infrarenal neck region, TBR did not decrease 
significantly between pre- and postprocedure scans. For the 
aneurysm sac and iliac regions, all obtained measures 
decreased significantly between the pre- and postprocedure 
scans.
Endobag migration of 30 mm was observed in 1 patient 
after 48 months, leading to a type Is2 endoleak (categorized 
according to the work of van den Ham et al19) and 7-mm sac 
enlargement. The SUVmax in the suprarenal region 
increased for this patient from 2.1 to 2.4 between the pre- 
and postprocedure FDG-PET/CT scans. All the SUVmax in 
the other regions remained unchanged or decreased. The 
patient refrained from further treatment. One other patient 
showed 8-mm device migration, a type Is2 endoleak, and 
sac growth of 4 mm after 24 months. At 30 months, the 
Nellix graft was explanted and replaced by an aortobifemo-
ral graft. No increase in SUVmax was observed for this 
patient.
Discussion
The present study has shown that FDG uptake after EVAS 
is significantly lower in the infrarenal and iliac segments 
compared to the preprocedure FDG uptake. This indicates 
that there is no increase in physiological inflammatory 
response of the aneurysm wall following EVAS. The pre-
procedure SUVmax results from our cohort were in range 
with those published for untreated AAAs and showed a 
homogenous uptake.20 Furthermore, these SUVmax results 
were higher compared to those obtained in nonaneurysmal 
aortas, indicating the presence of an inflammatory pro-
cess.20 Last, the homogenous uptake on postprocedure 
visual inspection were in line with previously published 
SUVmax data from Keidar and Nitecki.12
In general, the literature suggests a cutoff value for the 
SUVmax of 8 in the perigraft area to distinguish infected 
grafts from noninfected grafts.11,21 The SUVmax results in 
the current study were all far below this cutoff value. 
Tolenaar et al22 presented 2 cases of endograft infection 
after EVAS that both showed high focal uptake (SUV 7.2 
Table 1. Characteristics of the 8 Patients.a
Age, y 78 (71, 80)
Men 8






 Diabetes mellitus 0
 Hypertension 5
 Hyperlipidemia 3
 Cardiac disease 4
 Renal disease 5
 PAD 3
 Pulmonary disease 2
 Family history AAA 0
Abbreviations: AAA, abdominal aortic aneurysm; ASA, American Society 
of Anesthesiologists; PAD, peripheral artery disease.
aContinuous data are presented as the median (interquartile range Q1, 
Q3); categorical data are given as the number.
Table 2. FDG-PET/CT Scanning Parameters.a
Preprocedure Postprocedure
Glucose, mmol/L 5.5 (5.3, 6.6) 5.4 (5.2, 6.6)
FDG, MBq 251.0 (237, 267) 263 (234, 280)
Abbreviations: FDG, fluorine-18-fluorodeoxyglucose; PET/CT, positron 
emission tomography/computed tomography.
aData are presented as the median (interquartile range Q1, Q3).
Table 3. Procedure Details.a
General anesthesia 8
Bilateral cutdown 8
Procedure time, min 76 (69.8, 95)
Blood loss, mL 100 (75, 425)
Prefill volume, mL 108 (97.3, 133)
Prefill pressure, mm Hg 180 (180, 180)
Polymer volume, mL 107 (96.3, 133)
Filling pressure, mm Hg 185 (180, 197.5)
Secondary fill volume, mL 5 (3.5, 8.5)
Technical success 8
Hospital stay, d 3 (3, 4)
aContinuous data are presented as the median (interquartile range Q1, 
Q3); categorical data are given as the number.
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and SUV 9.7) in the infected area. The results of Tolenaar 
et al22 may justify the use of FDG-PET/CT as a diagnostic 
tool to identify infection after EVAS, particularly since the 
current study showed that the physiological uptake after 
EVAS is low. In addition, Zogala et al23 published a sensi-
tivity of 89% and a specificity of 100% based on SUVmax, 
TBR, and visual grading of FDG-PET/CT scans to diagnose 
stent-graft infection.
When analyzing the results per region, the suprarenal 
segment did not show a decrease in SUVmax in comparison 
to the infrarenal regions. The suprarenal region is not cov-
ered by the endobags; blood flow perturbations caused by 
the endobag plateau (creating a step in the aortic diameter) 
in this area could mediate inflammatory processes in the 
vessel wall and an increase in FDG uptake. An increased 
FDG uptake during follow-up could also be related to PIS, 
something that can be difficult to distinguish from true 
infection. Berg et al24 found that the incidence of PIS is sig-
nificantly lower after EVAS compared with a polyester 
stent-graft in EVAR, with a lower body temperature and 
lower serum leukocyte and C-reactive protein levels.24
Marie and colleagues16 recently reported no significant 
increase in FDG-PET/CT uptake between 3 months before 
EVAR and 4 weeks after treatment. The FDG-PET/CT 
uptake between 3 months pre-EVAR and 6 months thereaf-
ter significantly increased, both under the threshold for 
infection (SUVmax 2.2 vs 2.6, respectively). An explana-
tion between the decreased uptake we observed and the 
steady uptake shown by Marie et al16 after 4 weeks could be 
related to the high percentage of endoleaks (43% at 4 weeks 
and 39% at 6 months) in the Marie cohort, maintaining 
inflammatory processes in the vessel wall because of con-
tact with the circulation. Marie et al16 also reported 6-month 
data, but it is questionable if our short-term results can be 
extrapolated to the 6-month time point. Therefore, addi-
tional follow-up at 6 or 12 months would be of added value 
in future studies.
Along the same line, Courtois et al25 recently presented 
results about the predictive value of FDG-PET/CT in the 
detection of complications after EVAR. Our study cohort 
had 2 patients with complications (migration leading to 
type Ia endoleak and sac enlargement in both cases at 24 
and 48 months). The FDG-PET/CT data showed only a 
minor increase in activity for the suprarenal region in one of 
these patients between the pre- or postprocedure scan.
Limitations
Comparison of FDG-uptake values between studies should 
always be done with great care, as there may be differences 
in the PET/CT scanner performance and the acquisition and 
interpretation of the data, as was recognized by the EARL 
Table 4. Visual Assessment.
Patient No.
Gradea Uptake Pattern
Pre Post Pre Post
1 1 1 Homogenous Homogenous
2 1 1 Homogenous Homogenous
3 2 2 Slightly heterogeneous Slightly heterogeneous
4 1 1 Homogenous Homogenous
5 1 1 Homogenous Homogenous
6 1 1 Homogenous Homogenous
7 1 1 Homogenous Homogenous
8 1 1 Homogenous Homogenous
aGrade 1, an FDG (fluorine-18-fluorodeoxyglucose) uptake similar to that in the background; grade 2, low FDG uptake and is comparable with the 
FDG uptake by inactive muscles and fat; grade 3, moderate FDG uptake, clearly visible and higher than the uptake by inactive muscles and fat but 
distinctly less than the physiological uptake by the bladder; grade 4, a strong FDG uptake comparable to the physiological uptake by the bladder.
Table 5. Standard Uptake Value (SUV) and Tissue to 
Background Ratio (TBR) per Region.a
Parameter Preprocedure Postprocedure p
Suprarenal
 SUVmax 2.5 (2.1, 3.4) 2.5 (2.3, 3.1) 0.4
 TBR 0.9 (0.9, 1.0) 0.9 (0.9, 1) 0.5
Infrarenal neck
 SUVmax 2.8 (2.5, 3.2) 2.6 (2.2, 2.9) 0.036
 TBR 1.0 (0.9, 1.1) 1.0 (0.8, 1.0) 0.6
Aneurysm sac
 SUVmax 2.6 (2.4, 3.6) 2.0 (1.9, 3.0) 0.012
 TBR 1.0 (0.8, 1.1) 0.8 (0.8, 0.9) 0.017
Iliac
 SUVmax 2.8 (2.3, 3.8) 2.3 (2.1, 3.2) 0.012
 TBR 1.0 (0.9, 1.0) 0.9 (0.8, 1.0) 0.036
Mean of regions
 SUVmax 2.6 (2.3, 3.5) 2.2 (2.1, 3.0) 0.017
 TBR 1.0 (0.9, 1.0) 0.9 (0.9, 0.9) 0.069
aData are presented as the median (interquartile range Q1, Q3).
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standard.26 Furthermore, several methods exist to standard-
ize the FDG uptake, either using the ascending aorta or the 
mediastinum. This could induce differences in reported 
FDG uptake values. Our method consisted of sampling 4 
areas of the infrarenal vasculature using 5 slices per area. 
Other authors report results using all slices available; how-
ever, our software tool did not allow easy inclusion of a 
volume including all slices. This could influence the aver-
age FDG uptake per area.
Also, in AAAs without thrombus formation, the blood 
lumen (with high activity) is often partly included when 
assessing FDG uptake in the vessel wall. The EVAS endo-
bags (without any activity) are adjacent to the vessel wall, 
causing lower postprocedure SUVmax readings. Last, the 
current study did not include any patients with a graft infec-
tion, so no conclusions on the cutoff for graft infection after 
EVAS can be reported.
Conclusion
The current study shows there is no increase, but stable or 
decreased physiological FDG uptake after EVAS. Future 
research is needed to assess the applicability and cutoff val-
ues of FDG-PET/CT scanning to detect endograft infection 
after EVAS.
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